Home › Companies › PUMA BIOTECHNOLOGY INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and PUMA BIOTECHNOLOGY INC.’s Form 8-K, filed June 13, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 11, 2025: 10 items on PUMA BIOTECHNOLOGY INC.’s Form 8-K, filed June 13, 2025: 2 approved · 8 passed (calculated).
Significant dissent: 2 directors (30.6%, 25.5% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore PUMA BIOTECHNOLOGY INC. in the interactive database Compare manager voting policies
These tallies are PUMA BIOTECHNOLOGY INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Alan H. Auerbach | 34,639,223 | -- | -- | 408,312 | 6,521,146 | 99% | Passed (calculated) | — |
| Elect Director: Alessandra Cesano | 26,100,362 | -- | -- | 8,947,173 | 6,521,146 | 74% | Passed (calculated) | — |
| Elect Director: Allison Dorval | 34,757,965 | -- | -- | 289,570 | 6,521,146 | 99.2% | Passed (calculated) | — |
| Elect Director: Michael P. Miller | 34,501,336 | -- | -- | 546,199 | 6,521,146 | 98% | Passed (calculated) | — |
| Elect Director: Jay M. Moyes | 34,453,681 | -- | -- | 593,854 | 6,521,146 | 98% | Passed (calculated) | — |
| Elect Director: Adrian M. Senderowicz | 34,504,501 | -- | -- | 543,034 | 6,521,146 | 98% | Passed (calculated) | — |
| Elect Director: Brian Stuglik | 34,742,184 | -- | -- | 305,351 | 6,521,146 | 99.1% | Passed (calculated) | — |
| Elect Director: Troy E. Wilson | 24,308,330 | -- | -- | 10,739,205 | 6,521,146 | 69% | Passed (calculated) | — |
| 2. The selection of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2025 | 40,683,257 | 739,693 | 145,731 | -- | 0 | 98% | Approved | — |
| Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers. | 32,617,895 | 1,698,665 | 730,975 | -- | 6,521,146 | 95% | Approved | — |
Source: PUMA BIOTECHNOLOGY INC., Form 8-K, filed with the SEC on June 13, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
149 asset managers disclosed a vote on at least one PUMA BIOTECHNOLOGY INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 98.3% for (June 18, 2024 meeting) ▲ 0.2 pts
Description as filed by funds: Election of directors to serve for a one-year term: Adrian M. Senderowicz
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Adrian M. Senderowicz”): 34,504,501 for, 543,034 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 10,112,240 for, 14,244 withheld, 105,823 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,722,520 | 0 | 0 | 0 | For |
| BlackRock | 1,813,759 | 0 | 0 | 0 | For |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 328,839 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 127,312 | 0 | 0 | 0 | For |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 81,633 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 0 | 0 | 71,800 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 67,080 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 35,848 | 0 | 0 | 0 | For |
| EA Series Trust | 0 | 0 | 34,023 | 0 | Abstain |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Prior year: 98.5% for (June 18, 2024 meeting) ▲ 0.3 pts
Description as filed by funds: Election of directors to serve for a one-year term: Alan H. Auerbach
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Alan H. Auerbach”): 34,639,223 for, 408,312 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 10,218,063 for, 14,244 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,722,520 | 0 | 0 | 0 | For |
| BlackRock | 1,813,759 | 0 | 0 | 0 | For |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 328,839 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 127,312 | 0 | 0 | 0 | For |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 81,633 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 71,800 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 67,080 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 35,848 | 0 | 0 | 0 | For |
| EA Series Trust | 34,023 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
74% Majority: yes · of votes cast
Prior year: 81.7% for (June 18, 2024 meeting) ▼ 7.2 pts
Description as filed by funds: Election of directors to serve for a one-year term: Alessandra Cesano
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Alessandra Cesano”): 26,100,362 for, 8,947,173 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 74% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 3,803,989 for, 4,517,627 withheld, 1,910,691 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 86,986 | 0 | 0 | 3,635,534 | Withhold |
| BlackRock | 0 | 0 | 1,813,759 | 0 | Abstain |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 328,839 | Withhold |
| TARGET PORTFOLIO TRUST | 0 | 0 | 0 | 276,200 | Withhold |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 127,312 | Withhold |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 6,480 | 0 | 0 | 75,153 | Mixed |
| RBC FUNDS TRUST | 71,800 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 67,080 | 0 | Abstain |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 15,714 | 0 | 0 | 20,134 | Mixed |
| EA Series Trust | 34,023 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
Prior year: 97.2% for (June 18, 2024 meeting) ▲ 2.0 pts
Description as filed by funds: Election of directors to serve for a one-year term: Allison Dorval
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Allison Dorval”): 34,757,965 for, 289,570 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.2% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 10,222,289 for, 10,018 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,722,520 | 0 | 0 | 0 | For |
| BlackRock | 1,813,759 | 0 | 0 | 0 | For |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 328,839 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 127,312 | 0 | 0 | 0 | For |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 81,633 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 71,800 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 67,080 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 35,848 | 0 | 0 | 0 | For |
| EA Series Trust | 34,023 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Prior year: 98.3% for (June 18, 2024 meeting) ▲ 0.8 pts
Description as filed by funds: Election of directors to serve for a one-year term: Brian Stuglik
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Brian Stuglik”): 34,742,184 for, 305,351 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 10,222,118 for, 10,189 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,722,520 | 0 | 0 | 0 | For |
| BlackRock | 1,813,759 | 0 | 0 | 0 | For |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 328,839 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 127,312 | 0 | 0 | 0 | For |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 81,633 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 71,800 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 67,080 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 35,848 | 0 | 0 | 0 | For |
| EA Series Trust | 34,023 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 98.2% for (June 18, 2024 meeting) ▲ 0.1 pts
Description as filed by funds: Election of directors to serve for a one-year term: Jay M. Moyes
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Jay M. Moyes”): 34,453,681 for, 593,854 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 10,222,118 for, 10,189 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,722,520 | 0 | 0 | 0 | For |
| BlackRock | 1,813,759 | 0 | 0 | 0 | For |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 328,839 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 127,312 | 0 | 0 | 0 | For |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 81,633 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 71,800 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 67,080 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 35,848 | 0 | 0 | 0 | For |
| EA Series Trust | 34,023 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Prior year: 97.7% for (June 18, 2024 meeting) ▲ 0.8 pts
Description as filed by funds: Election of directors to serve for a one-year term: Michael P. Miller
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Michael P. Miller”): 34,501,336 for, 546,199 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 10,112,240 for, 14,244 withheld, 105,823 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,722,520 | 0 | 0 | 0 | For |
| BlackRock | 1,813,759 | 0 | 0 | 0 | For |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 328,839 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 127,312 | 0 | 0 | 0 | For |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 81,633 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 0 | 0 | 71,800 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 67,080 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 35,848 | 0 | 0 | 0 | For |
| EA Series Trust | 0 | 0 | 34,023 | 0 | Abstain |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
69% Majority: yes · of votes cast
Prior year: 78.4% for (June 18, 2024 meeting) ▼ 9.1 pts
Description as filed by funds: Election of directors to serve for a one-year term: Troy E. Wilson
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Elect Director: Troy E. Wilson”): 24,308,330 for, 10,739,205 withheld, per its Form 8-K filed June 13, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 69% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 3,359,977 for, 4,855,816 withheld, 2,016,514 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 86,986 | 0 | 0 | 3,635,534 | Withhold |
| BlackRock | 0 | 0 | 1,813,759 | 0 | Abstain |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 328,839 | Withhold |
| TARGET PORTFOLIO TRUST | 0 | 0 | 0 | 276,200 | Withhold |
| Federated Hermes | 0 | 0 | 0 | 193,766 | Withhold |
| BRIDGEWAY FUNDS INC | 141,300 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 127,312 | Withhold |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 81,633 | Withhold |
| RBC FUNDS TRUST | 0 | 0 | 71,800 | 0 | Abstain |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 67,080 | 0 | Abstain |
| Delaware/Macquarie | 0 | 0 | 0 | 61,255 | Withhold |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 15,714 | 0 | 0 | 20,134 | Mixed |
| EA Series Trust | 0 | 0 | 34,023 | 0 | Abstain |
| Lincoln Financial | 3,378 | 0 | 0 | 29,500 | Mixed |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
95% Approved · of votes cast
Prior year: 95.7% for (June 18, 2024 meeting) ▼ 0.6 pts
Description as filed by funds: ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF PUMA BIOTECHNOLOGY, INC.'S NAMED EXECUTIVE OFFICERS AS DESCRIBED IN THE PROXY STATEMENT.
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“Proposal 3: The Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers.”): 32,617,895 for, 1,698,665 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3: The Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,722,520 | 0 | 0 | 0 | For |
| BlackRock | 1,813,759 | 0 | 0 | 0 | For |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 0 | 410,482 | 0 | 0 | Against |
| SEI | 328,839 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 141,300 | 0 | 0 | Against |
| Charles Schwab | 127,312 | 0 | 0 | 0 | For |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 81,633 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 71,800 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 67,080 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 35,848 | 0 | 0 | 0 | For |
| EA Series Trust | 34,023 | 0 | 0 | 0 | For |
| Lincoln Financial | 29,500 | 3,378 | 0 | 0 | Mixed |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Fund voting reports, all 57 managers: 9,648,871 for, 576,827 against, 10,018 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,491,877 | 0 | 0 | 0 | For |
| American Century | 1,199,517 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 967,097 | 0 | 0 | 0 | For |
| Renaissance | 810,228 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 638,594 | 96,405 | 0 | 0 | Mixed |
| State Street | 595,819 | 2,376 | 0 | 0 | For |
| DE Shaw | 513,242 | 0 | 0 | 0 | For |
| GLOBEFLEX CAPITAL L P | 390,272 | 0 | 0 | 0 | For |
| SEI | 336,396 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 295,497 | 0 | 0 | 0 | For |
| Prudential/PGIM | 289,835 | 0 | 0 | 0 | For |
| Eversept Partners, LP | 275,788 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 275,565 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 224,133 | 0 | 0 | 0 | For |
| Two Sigma | 222,285 | 0 | 0 | 0 | For |
| Northern Trust | 210,919 | 0 | 0 | 0 | For |
| Federated Hermes | 198,819 | 0 | 0 | 0 | For |
| Newton Investment Management North America, LLC | 160,800 | 0 | 0 | 0 | For |
| MACKENZIE FINANCIAL CORP | 157,713 | 0 | 0 | 0 | For |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 143,386 | 7,436 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 149,100 | 0 | 0 | Against |
| STRS OHIO | 141,900 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 137,882 | 0 | 0 | 0 | For |
| Fidelity | 128,443 | 0 | 0 | 0 | For |
| Charles Schwab | 127,319 | 0 | 0 | 0 | For |
Institutional-manager reports, all 111 managers: 10,863,475 for, 463,896 against, 120 abstained. Showing the 25 largest; every one is in the interactive database (link above).
98% Approved · of votes cast
Prior year: 99.0% for (June 18, 2024 meeting) ▼ 0.8 pts
Description as filed by funds: RATIFICATION OF THE SELECTION OF KPMG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF PUMA BIOTECHNOLOGY, INC. FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
PUMA BIOTECHNOLOGY INC.’s own tally for this item (“2. The selection of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2025”): 40,683,257 for, 739,693 against — passed, per its Form 8-K filed June 13, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: The Company's stockholders ratified the selection of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2025.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 10,046,149 for, 179,549 against, 10,018 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,722,520 | 0 | 0 | 0 | For |
| BlackRock | 1,813,759 | 0 | 0 | 0 | For |
| American Century | 1,176,354 | 0 | 0 | 0 | For |
| Fidelity | 1,059,127 | 0 | 0 | 0 | For |
| Dimensional | 410,482 | 0 | 0 | 0 | For |
| SEI | 328,839 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 276,200 | 0 | 0 | 0 | For |
| Federated Hermes | 193,766 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 141,300 | 0 | 0 | Against |
| Charles Schwab | 127,312 | 0 | 0 | 0 | For |
| WisdomTree | 83,143 | 0 | 0 | 0 | For |
| Equitable | 81,633 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 71,800 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 67,080 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 61,255 | 0 | 0 | 0 | For |
| TIAA | 55,922 | 0 | 0 | 0 | For |
| GPS Funds I | 43,280 | 0 | 0 | 0 | For |
| Virtus | 41,614 | 0 | 0 | 0 | For |
| Goldman Sachs | 40,114 | 0 | 0 | 0 | For |
| Pacific Life | 35,848 | 0 | 0 | 0 | For |
| EA Series Trust | 0 | 34,023 | 0 | 0 | Against |
| Lincoln Financial | 32,878 | 0 | 0 | 0 | For |
| Legg Mason | 32,690 | 0 | 0 | 0 | For |
| Putnam | 31,246 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 27,546 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 49,638,093 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 7.50% |
| 2 | BlackRock | 3.65% |
| 3 | American Century | 2.37% |
| 4 | Fidelity | 2.13% |
| 5 | Dimensional | 0.83% |
| 6 | SEI | 0.66% |
| 7 | TARGET PORTFOLIO TRUST | 0.56% |
| 8 | Federated Hermes | 0.39% |
| 9 | BRIDGEWAY FUNDS INC | 0.28% |
| 10 | Charles Schwab | 0.26% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 3.01% |
| 2 | American Century | 2.42% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 1.95% |
| 4 | Renaissance | 1.63% |
| 5 | KENNEDY CAPITAL MANAGEMENT LLC | 1.48% |
| 6 | State Street | 1.21% |
| 7 | DE Shaw | 1.03% |
| 8 | GLOBEFLEX CAPITAL L P | 0.79% |
| 9 | SEI | 0.68% |
| 10 | Connor, Clark & Lunn Investment Management Ltd. | 0.60% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Anders Hove | 3,940,052 | 7.94% | Schedule 13G, filed February 14, 2025 |
| BlackRock | 3,847,368 | 7.75% | Form 13F, quarter ended March 31, 2025 |
| Vanguard Group | 3,669,263 | 7.39% | Form 13F, quarter ended March 31, 2025 |
| Renaissance Technologies | 1,829,213 | 3.69% | Form 13F, quarter ended March 31, 2025 |
| Millennium Management | 1,385,194 | 2.79% | Form 13F, quarter ended March 31, 2025 |
| Geode Capital | 955,456 | 1.92% | Form 13F, quarter ended March 31, 2025 |
| Dimensional Fund Advisors | 888,663 | 1.79% | Form 13F, quarter ended March 31, 2025 |
| State Street | 649,792 | 1.31% | Form 13F, quarter ended March 31, 2025 |
| D.E. Shaw | 571,665 | 1.15% | Form 13F, quarter ended March 31, 2025 |
| BNY Mellon | 340,886 | 0.69% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 49,638,093 shares outstanding, as reported by PUMA BIOTECHNOLOGY INC. on its Form 10-Q dated May 5, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At PUMA BIOTECHNOLOGY INC.'s shareholder meeting held June 11, 2025, in the 2024-2025 proxy season, 149 asset managers reported votes on at least one of its 10 ballot items in their SEC Form N-PX filings, covering 1,532 separate fund positions. On the most widely held item on that ballot — ADVISORY (NON-BINDING) VOTE TO APPROVE THE COMPENSATION OF PUMA BIOTECHNOLOGY, INC.'S NAMED… — PUMA BIOTECHNOLOGY INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: PUMA BIOTECHNOLOGY INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PUMA BIOTECHNOLOGY INC.’s 10-Q dated May 5, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
PUMA BIOTECHNOLOGY INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “PUMA BIOTECHNOLOGY (PBYI) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/puma-biotechnology-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.